ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
19 hedge funds and large institutions have $91.6M invested in Anebulo Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 21 → 19 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$295K | |
| 2 | +$68.5K | |
| 3 | +$55.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.82K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.38K |
Top Sellers
| 1 | -$319K | |
| 2 | -$47.9K | |
| 3 | -$47.1K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$30.5K |
| 5 |
Renaissance Technologies
New York
|
-$7.76K |
